Here are relevant reports on : game-development-market
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Mobile Middleware Market by Software (Mobile Application Development Platform, Mobile Asset Management, Mobile Operating System, MDM, and MAM), by Service (System Integration, Training & Support, and Consulting) - Global Forecasts to 2019
The report aims in estimating the future growth potential in the active areas including: software, services, end-user, and deployment types across the verticals and regions. The global mobile middleware market is segmented on the basis of regions such as NA, Europe, APAC, MEA, and LA. The global mobile middleware market is provided for each region from 2014 to 2019. The global mobile middleware market is expected to grow from $1470.0 million in 2014 to $3726.1 million in 2019 at a CAGR of 20.4%.
- Published: February 2015
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Digital Mining Market by Services (Advisory, Technical, Business, Managed IT), Mining Type (Surface Mining, Underground Mining), and Application (Exploration, Assessment, Development, Production Operation, Reclamation) - Global Forecast to 2030
The digital mining market is projected to grow from USD 0.45 billion in 2025 to USD 0.74 billion by 2030, at a CAGR of 10.8% during the forecast period. The report profiles key players, such as Wipro (India), Metso (Finland), ABB (Switzerland), Rockwell Automation (US), Cyient (India), FLSmidth (Denmark), Caterpillar (US), Sandvik (Sweden), Schneider Electric (France), Accenture (Ireland), Microsoft (US), IBM (US), and Siemens (Germany). These players have employed various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to enhance their international presence and increase their market share in the digital mining sector. These strategies have allowed the market players to expand across geographies by offering digital mining solutions.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Asia Pacific Digital Twin Market by Application (Product Design & Development, Performance Monitoring, Predictive Maintenance, Inventory Management, Business Optimization), Industry (Automotive & Transportation, Infrastructure) - Forecast to 2030
The Asia Pacific digital twin market is expected to be valued at USD 4.57 billion in 2025 and USD 32.57 billion by 2030, registering a CAGR of 48.1% during the forecast period. The Key Players include market Fresenius SE & Co. KGaA (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Danone S.A. (France), B. Braun Melsungen AG. (US), Nestlé S.A. (Switzerland), , Boston Scientific Corporation (US), Becton, Dickinson and Company (US), CONMED Corporation (US), Baxter International Inc. (US), Abbott (US), Moog, Inc. (US), Cook Medical (US), Terumo Corporation (Japan), Weigao Medical International Co., Ltd. (China), JMS Co., Ltd. (Japan), Vygon (France), Applied Medical Technology (US), Amsino International Inc. (US), and Medela AG (Switzerland).
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
